Glucopyranosyl-substituted benzene derivatives defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.

 
Web www.patentalert.com

< Surface activated biochip

> Avermectin and avermectin monosaccharide substituted in the 4''- and 4'' position respectively

> Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same
~ 00593